Highlights
- Market Cap
- $32.76B
- Enterprise Value
- $29.27B
- EPS (TTM)
- $3.66
- PE Ratio
- 19.42
- Total Revenue (TTM)
- $19.60B
- Gross Profit (TTM)
- $8.53B
- EBITDA (TTM)
- $3.58B
- Year Range
- $57.65 - $89.77
- Target Price
- $91.30
- ROA (TTM)
- 4.55%
- ROE (TTM)
- 16.19%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in GE HealthCare Technologies Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
GE HealthCare Technologies Inc. (GEHC) has returned -13.18% so far this year and -11.65% over the past 12 months.
GE HealthCare Technologies Inc.
- 1D
- 3.50%
- 1M
- -15.53%
- YTD
- -13.18%
- 6M
- -5.14%
- 1Y
- -11.65%
- 3Y*
- -4.46%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 4, 2023, GEHC's average daily return is +0.04%, while the average monthly return is +0.76%. At this rate, your investment would double in approximately 7.6 years.
Historically, 49% of months were positive and 51% were negative. The best month was Feb 2024 with a return of +24.4%, while the worst month was Apr 2024 at -16.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.
On a daily basis, GEHC closed higher 49% of trading days. The best single day was Feb 6, 2024 with a return of +11.7%, while the worst single day was Apr 4, 2025 at -16.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.68% | 6.71% | -15.53% | -13.18% | |||||||||
| 2025 | 12.99% | -1.08% | -7.60% | -12.82% | 0.30% | 5.00% | -3.67% | 3.38% | 1.86% | -0.15% | 6.72% | 2.54% | 5.11% |
| 2024 | -5.08% | 24.43% | -0.41% | -16.11% | 2.31% | -0.10% | 8.65% | 0.22% | 10.65% | -6.90% | -4.73% | -6.06% | 1.26% |
| 2023 | 14.93% | 9.32% | 7.93% | -0.84% | -2.21% | 2.18% | -3.95% | -9.68% | -3.42% | -2.12% | 2.84% | 12.94% | 27.98% |
Benchmark Metrics
GE HealthCare Technologies Inc. has an annualized alpha of -9.53%, beta of 1.16, and R² of 0.30 versus S&P 500 Index. Calculated based on daily prices since January 05, 2023.
- This stock participated in 175.14% of S&P 500 Index downside but only 98.25% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.30 means the benchmark explains less than half of this stock's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -9.53%
- Beta
- 1.16
- R²
- 0.30
- Upside Capture
- 98.25%
- Downside Capture
- 175.14%
Return for Risk
Risk / Return Rank
GEHC ranks 25 for risk / return — below 25% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GE HealthCare Technologies Inc. (GEHC) and compare them to a chosen benchmark (S&P 500 Index).
| GEHC | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.31 | 0.90 | -1.21 |
Sortino ratioReturn per unit of downside risk | -0.18 | 1.39 | -1.57 |
Omega ratioGain probability vs. loss probability | 0.97 | 1.21 | -0.24 |
Calmar ratioReturn relative to maximum drawdown | -0.40 | 1.40 | -1.80 |
Martin ratioReturn relative to average drawdown | -1.01 | 6.61 | -7.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore GEHC risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
GE HealthCare Technologies Inc. provided a 0.20% dividend yield over the last twelve months, with an annual payout of $0.14 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Dividend | $0.14 | $0.14 | $0.12 | $0.09 |
Dividend yield | 0.20% | 0.17% | 0.15% | 0.12% |
Monthly Dividends
The table displays the monthly dividend distributions for GE HealthCare Technologies Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.04 | $0.00 | $0.00 | $0.04 | |||||||||
| 2025 | $0.04 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.14 |
| 2024 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.12 |
| 2023 | $0.03 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.09 |
Dividend Yield & Payout
Dividend Yield
GE HealthCare Technologies Inc. has a dividend yield of 0.20%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
GE HealthCare Technologies Inc. has a payout ratio of 3.69%, which is below the market average. This means GE HealthCare Technologies Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the GE HealthCare Technologies Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GE HealthCare Technologies Inc. was 37.35%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current GE HealthCare Technologies Inc. drawdown is 23.96%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -37.35% | Oct 1, 2024 | 130 | Apr 8, 2025 | — | — | — |
| -28.04% | Apr 25, 2023 | 130 | Oct 27, 2023 | 80 | Feb 23, 2024 | 210 |
| -20.35% | Mar 11, 2024 | 65 | Jun 11, 2024 | 76 | Sep 30, 2024 | 141 |
| -5.44% | Jan 13, 2023 | 3 | Jan 18, 2023 | 2 | Jan 20, 2023 | 5 |
| -4.8% | Feb 7, 2023 | 3 | Feb 9, 2023 | 3 | Feb 14, 2023 | 6 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of GE HealthCare Technologies Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how GE HealthCare Technologies Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GEHC, comparing it with other companies in the Health Information Services industry. Currently, GEHC has a P/E ratio of 19.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GEHC relative to other companies in the Health Information Services industry. Currently, GEHC has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GEHC in comparison with other companies in the Health Information Services industry. Currently, GEHC has a P/B value of 3.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |